Meg Jardine's Publications

• Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply

  Journal articles

  2019

  The New England journal of medicine

• Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial

  Journal articles

  2019

  Circulation

• The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study

  Journal articles

  2019

  Quality of Life Research

• Benefits and harms of oral anticoagulant therapy in chronic kidney disease

  Journal articles

  2019

  Annals of Internal Medicine

• Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study

  Journal articles

  2019

  BMC Nephrology

• Cardiovascular adaptations associated with exercise in patients on hemodialysis

  Journal articles

  2019

  Seminars in Dialysis

• Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial

  Journal articles

  2019

  Journal of Renal Nutrition

• Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

  Journal articles

  2019

  New England Journal of Medicine

• 1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence

  Conference Abstracts

  2019

  Diabetes

• 1130-P: Temporal Trends in Pharmacotherapy for Diabetes

  Conference Abstracts

  2019

  Diabetes

• Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis

  Journal articles

  2019

  Nephrology

• Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

  Journal articles

  2019

  Diabetes, Obesity and Metabolism

• Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials

  Journal articles

  2019

  BMC Cardiovascular Disorders

• Effect of extended hours dialysis on sleep quality in a randomized trial

  Journal articles

  2019

  Nephrology

• Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

  Journal articles

  2019

  PLoS ONE

• Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018

  Journal articles

  2019

  Canadian Journal of Kidney Health and Disease

• Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort

  Journal articles

  2019

  Canadian Journal of Kidney Health and Disease

• Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program

  Journal articles

  2019

  Journal of the American Society of Nephrology

• Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units

  Journal articles

  2019

  Nephrology

• Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

  Journal articles

  2019

  BMJ Open

• Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol

  Journal articles

  2019

  BMJ Open

• SAT-041 A META-ANALYSIS OF THE REPRESENTATIVENESS OF RANDOMIZED CONTROLLED TRIAL COHORTS IN END-STAGE KIDNEY DISEASE

  Journal articles

  2019

  Kidney International Reports

• Abstract 259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin

  Journal articles

  2019

  Endocrine Practice

• SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEYDISEASE

  Journal articles

  2019

  Kidney International Reports

• SAT-241 SMALL AREA-LEVEL VARIATION IN CHRONIC KIDNEY DISEASE PREVALENCE AND INCIDENCE IN NEW SOUTH WALES

  Journal articles

  2019

  Kidney International Reports

• SAT-288 Trends in pharmacotherapy for diabetes in a large Australian cohort: results from the EXTEND45 study

  Journal articles

  2019

  Kidney International Reports